Issue 41, 2024, Issue in Progress

Ethylene oxide graft copolymers reduce the immunogenicity of lipid nanoparticles

Abstract

Lipid nanoparticle (LNP)/mRNA complexes have great therapeutic potential but their PEG chains can induce the production of anti-PEG antibodies. New LNPs that do not contain PEG are greatly needed. We demonstrate here that poly-glutamic acid-ethylene oxide graft copolymers can replace the PEG on LNPs and outperform PEG-LNPs after chronic administration.

Graphical abstract: Ethylene oxide graft copolymers reduce the immunogenicity of lipid nanoparticles

Supplementary files

Transparent peer review

To support increased transparency, we offer authors the option to publish the peer review history alongside their article.

View this article’s peer review history

Article information

Article type
Paper
Submitted
11 Jul 2024
Accepted
10 Sep 2024
First published
20 Sep 2024
This article is Open Access
Creative Commons BY-NC license

RSC Adv., 2024,14, 30071-30076

Ethylene oxide graft copolymers reduce the immunogenicity of lipid nanoparticles

Y. Qi, H. Han, A. Liu, S. Zhao, A. Lawanprasert, J. E. Nielsen, H. Choudhary, D. Liang, A. E. Barron and N. Murthy, RSC Adv., 2024, 14, 30071 DOI: 10.1039/D4RA05007J

This article is licensed under a Creative Commons Attribution-NonCommercial 3.0 Unported Licence. You can use material from this article in other publications, without requesting further permission from the RSC, provided that the correct acknowledgement is given and it is not used for commercial purposes.

To request permission to reproduce material from this article in a commercial publication, please go to the Copyright Clearance Center request page.

If you are an author contributing to an RSC publication, you do not need to request permission provided correct acknowledgement is given.

If you are the author of this article, you do not need to request permission to reproduce figures and diagrams provided correct acknowledgement is given. If you want to reproduce the whole article in a third-party commercial publication (excluding your thesis/dissertation for which permission is not required) please go to the Copyright Clearance Center request page.

Read more about how to correctly acknowledge RSC content.

Social activity

Spotlight

Advertisements